Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Borghetti

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Critical Reviews in Oncology/Hematology|August 6, 2021
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's LymphomaMichela Buglione, Andrea Emanuele Guerini, Andrea Riccardo Filippi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2022
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade StudyCarlotta Palumbo, Alberto Dalla Volta, Stefania Zamboni, et al.
Critical Reviews in Oncology/Hematology|February 24, 2019
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1Pierpaolo Alongi, Riccardo Laudicella, Isacco Desideri, et al.
Critical Reviews in Oncology/Hematology|April 4, 2019
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2Alba Fiorentino, Riccardo Laudicella, Elisa Ciurlia, et al.
La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.
Frontiers in Oncology|February 15, 2024
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, et al.
Technology in Cancer Research & Treatment|June 18, 2025
The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature ReviewAndrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Biomolecules|March 28, 2026
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot StudyGiorgio Facheris, Alessio Bruni, Valerio Nardone, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2020
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experienceAlessandro Alghisi, Paolo Borghetti, Marta Maddalo, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Critical Reviews in Oncology/Hematology|August 6, 2021
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's LymphomaMichela Buglione, Andrea Emanuele Guerini, Andrea Riccardo Filippi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2022
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade StudyCarlotta Palumbo, Alberto Dalla Volta, Stefania Zamboni, et al.
Critical Reviews in Oncology/Hematology|February 24, 2019
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1Pierpaolo Alongi, Riccardo Laudicella, Isacco Desideri, et al.
Critical Reviews in Oncology/Hematology|April 4, 2019
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2Alba Fiorentino, Riccardo Laudicella, Elisa Ciurlia, et al.
La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.
Frontiers in Oncology|February 15, 2024
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, et al.
Technology in Cancer Research & Treatment|June 18, 2025
The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature ReviewAndrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Biomolecules|March 28, 2026
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot StudyGiorgio Facheris, Alessio Bruni, Valerio Nardone, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2020
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experienceAlessandro Alghisi, Paolo Borghetti, Marta Maddalo, et al.
Journal of Neuro-Oncology|May 5, 2019
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trialSara Pedretti, Laura Masini, Enrico Turco, et al.
Pageof 13